General MedicationsORALStandard
BACLOFEN
BACLOFEN
Standard Dose
25MG/5ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview BACLOFEN is listed in Drugs@FDA under application 217252 (ANDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient BACLOFEN Form and strength SUSPENSION;ORAL - 25MG/5ML Sponsor ANI PHARMS Submission history Latest submission status date: 2023-06-08 00:00:00.
Structured Monograph
Clinical summary
Approval overview BACLOFEN is listed in Drugs@FDA under application 217252 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient BACLOFEN Form and strength SUSPENSION;ORAL - 25MG/5ML Sponsor ANI PHARMS Submission history Latest submission status date: 2023-06-08 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.